Estabrook Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.26M | Buy |
329,763
+52,428
| +19% | +$1.4M | 1.35% | 21 |
|
|
2025
Q4 | $6.91M | Sell |
277,335
-26,115
| -9% | -$659K | 1.01% | 28 |
|
|
2025
Q3 | $7.73M | Sell |
303,450
-15,475
| -5% | -$382K | 1.13% | 27 |
|
|
2025
Q2 | $7.73M | Buy |
318,925
+17,615
| +6% | +$411K | 1.19% | 24 |
|
|
2025
Q1 | $7.64M | Buy |
301,310
+5,280
| +2% | +$138K | 1.23% | 23 |
|
|
2024
Q4 | $7.85M | Sell |
296,030
-64,456
| -18% | -$1.75M | 1.21% | 22 |
|
|
2024
Q3 | $10.4M | Sell |
360,486
-540
| -0.1% | -$15.8K | 1.56% | 17 |
|
|
2024
Q2 | $10.1M | Buy |
361,026
+1,148
| +0.3% | +$31.6K | 1.55% | 16 |
|
|
2024
Q1 | $9.99M | Buy |
359,878
+44,806
| +14% | +$1.24M | 1.54% | 18 |
|
|
2023
Q4 | $9.07M | Sell |
315,072
-18,145
| -5% | -$549K | 1.48% | 19 |
|
|
2023
Q3 | $11.1M | Buy |
333,217
+26,208
| +9% | +$927K | 1.95% | 12 |
|
|
2023
Q2 | $11.3M | Sell |
307,009
-593
| -0.2% | -$23.1K | 1.88% | 12 |
|
|
2023
Q1 | $12.6M | Sell |
307,602
-821
| -0.3% | -$35.5K | 2.18% | 10 |
|
|
2022
Q4 | $15.8M | Buy |
308,423
+3,273
| +1% | +$157K | 2.72% | 8 |
|
|
2022
Q3 | $13.4M | Buy |
305,150
+2,893
| +1% | +$141K | 2.48% | 10 |
|
|
2022
Q2 | $15.8M | Sell |
302,257
-1,690
| -0.6% | -$86.1K | 2.72% | 7 |
|
|
2022
Q1 | $15.7M | Buy |
303,947
+190
| +0.1% | +$9.86K | 2.31% | 9 |
|
|
2021
Q4 | $17.9M | Sell |
303,757
-7,807
| -3% | -$387K | 2.54% | 7 |
|
|
2021
Q3 | $13.4M | Sell |
311,564
-9,359
| -3% | -$415K | 2.11% | 14 |
|
|
2021
Q2 | $12.6M | Sell |
320,923
-12,665
| -4% | -$493K | 1.91% | 15 |
|
|
2021
Q1 | $12.1M | Sell |
333,588
-558
| -0.2% | -$19.8K | 1.86% | 16 |
|
|
2020
Q4 | $12.3M | Sell |
334,146
-18,452
| -5% | -$677K | 2.04% | 13 |
|
|
2020
Q3 | $12.3M | Sell |
352,598
-6,463
| -2% | -$227K | 2.25% | 11 |
|
|
2020
Q2 | $11.1M | Sell |
359,061
-5,254
| -1% | -$178K | 2.12% | 12 |
|
|
2020
Q1 | $11.3M | Sell |
364,315
-13,953
| -4% | -$475K | 2.37% | 12 |
|
|
2019
Q4 | $14.1M | Buy |
378,268
+17,017
| +5% | +$606K | 2.11% | 15 |
|
|
2019
Q3 | $12.3M | Sell |
361,251
-1,107
| -0.3% | -$40.3K | 2.05% | 14 |
|
|
2019
Q2 | $14.9M | Sell |
362,358
-6,042
| -2% | -$240K | 2.44% | 13 |
|
|
2019
Q1 | $14.8M | Sell |
368,400
-2,352
| -0.6% | -$94.2K | 2.46% | 12 |
|
|
2018
Q4 | $15.4M | Sell |
370,752
-8,938
| -2% | -$371K | 2.85% | 7 |
|
|
2018
Q3 | $15.9M | Sell |
379,690
-27,324
| -7% | -$1.05M | 2.4% | 14 |
|
|
2018
Q2 | $14M | Sell |
407,014
-21,149
| -5% | -$723K | 2.21% | 16 |
|
|
2018
Q1 | $14.4M | Sell |
428,163
-3,532
| -0.8% | -$121K | 2.26% | 13 |
|
|
2017
Q4 | $14.8M | Sell |
431,695
-6,434
| -1% | -$219K | 2.24% | 14 |
|
|
2017
Q3 | $14.8M | Buy |
438,129
+526
| +0.1% | +$16.9K | 2.31% | 13 |
|
|
2017
Q2 | $13.9M | Buy |
437,603
+5,081
| +1% | +$160K | 2.22% | 14 |
|
|
2017
Q1 | $14M | Sell |
432,522
-10,248
| -2% | -$323K | 2.2% | 15 |
|
|
2016
Q4 | $13.6M | Sell |
442,770
-39,789
| -8% | -$1.21M | 2.14% | 15 |
|
|
2016
Q3 | $15.5M | Sell |
482,559
-7,829
| -2% | -$262K | 2.28% | 13 |
|
|
2016
Q2 | $16.4M | Sell |
490,388
-24,669
| -5% | -$787K | 2.45% | 12 |
|
|
2016
Q1 | $14.5M | Sell |
515,057
-6,252
| -1% | -$179K | 2.14% | 16 |
|
|
2015
Q4 | $16M | Sell |
521,309
-9,469
| -2% | -$298K | 2.31% | 15 |
|
|
2015
Q3 | $15.8M | Sell |
530,778
-13,055
| -2% | -$419K | 2.28% | 18 |
|
|
2015
Q2 | $17.3M | Sell |
543,833
-21,431
| -4% | -$698K | 2.14% | 21 |
|
|
2015
Q1 | $18.7M | Sell |
565,264
-27,988
| -5% | -$890K | 2.18% | 17 |
|
|
2014
Q4 | $17.5M | Sell |
593,252
-8,012
| -1% | -$230K | 1.93% | 21 |
|
|
2014
Q3 | $16.9M | Buy |
601,264
+10,965
| +2% | +$308K | 1.81% | 24 |
|
|
2014
Q2 | $16.6M | Buy |
590,299
+88,804
| +18% | +$2.53M | 1.71% | 28 |
|
|
2014
Q1 | $15.3M | Sell |
501,495
-13,958
| -3% | -$416K | 1.56% | 30 |
|
|
2013
Q4 | $15M | Buy |
515,453
+2,666
| +0.5% | +$77.6K | 1.54% | 27 |
|
|
2013
Q3 | $14M | Sell |
512,787
-11,594
| -2% | -$315K | 1.53% | 27 |
|
|
2013
Q2 | $13.9M | Buy |
+524,381
| New | +$14.5M | 1.48% | 29 |
|
Other funds holding PFE
VCM
VPM
Estabrook Capital Management's PFE Position: Q1 2026 in Review
Estabrook Capital Management increased its Pfizer (PFE) stake by 19% in Q1 2026, buying an estimated $1.4M and bringing the position to 329,763 shares worth $9.26M. The position accounts for 1.35% of the portfolio, ranked #21.
Estabrook Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.7M in Q1 2015. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Estabrook Capital Management held 329,763 shares of Pfizer worth $9.26M as of Q1 2026.
- Estabrook Capital Management bought 52,428 Pfizer shares in Q1 2026, an estimated $1.4M.
- Pfizer made up 1.35% of Estabrook Capital Management's portfolio in Q1 2026, its #21 holding.
- Estabrook Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Estabrook Capital Management's Pfizer position peaked at $18.7M in Q1 2015.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.